Tenaya Therapeutics Cash Flow Statement (2020-2026) | TNYA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-15.21M	-18.26M	-26.15M	-31.06M	-28.40M	-30.70M	-33.52M	-31.74M	-33.27M	-29.14M	-29.93M	-32.23M	-29.43M	-25.63M	-23.84M	-26.86M	-23.28M	-20.27M	-20.18M	-19.27M
Share-based Compensation (Quarter)	0.50M	0.97M	1.05M	2.09M	3.01M	3.17M	3.19M	3.51M	3.83M	4.01M	3.95M	4.22M	4.61M	3.91M	3.76M	0.40M	3.63M	2.93M	2.75M	2.20M
Gains from Sales and Divestitures (Quarter)	0.07M	0.10M				0.01M	0.01M	0.01M	0.01M	0.25M	0.25M	0.24M	0.26M	0.60M	0.69M	0.30M	0.49M	0.73M	0.91M	0.24M
Gains from Investment Securities (Quarter)	442.00	0.04M	-1.36M	-0.03M	0.04M	2.53M	-0.68M	0.06M	8.13M	0.91M	-0.88M	-0.00M	10.45M	1.31M	0.67M	1.47M	12.22M	3.83M	0.57M	0.21M
Non-cash Items (Quarter)	8.40M	14.30M	0.71M				1.72M				25.00M				0.41M				7.13M
Cash from Operations (Quarter)	-12.02M	-16.66M	-16.35M	-28.76M	-25.43M	-27.56M	-22.68M	-30.29M	-26.22M	-23.64M	-21.92M	-28.66M	-23.62M	-19.84M	-18.39M	-23.11M	-15.61M	-15.60M	-13.94M	-19.23M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.26M	0.31M	-0.61M	0.14M	0.65M	-0.72M	-0.38M	-0.57M	2.10M	0.80M	0.81M	-0.07M	1.70M	1.03M	-2.84M	0.60M	0.61M	0.62M	-1.42M	0.65M
Depreciation & Amortization (CF) (Quarter)	0.73M	0.75M	0.79M	0.97M	1.30M	2.09M	2.12M	2.13M	2.19M	2.18M	2.18M	2.15M	2.12M	2.10M	2.09M	2.66M	2.08M	1.86M	1.83M	1.76M
Change in Working Capital
Change in Receivables (Quarter)																				10.63M
Change in Account Payables (Quarter)	0.74M	1.16M	6.08M	-1.78M	-0.34M	0.32M	3.46M	-1.32M	1.10M	-2.75M	-0.30M	1.27M	-2.43M	1.28M	-0.70M	-0.38M	-1.14M	-0.45M	0.53M	-1.46M
Change in Accured Expenses (Quarter)	0.99M	1.76M	1.57M	0.32M	0.39M	1.34M	2.30M	-2.66M	1.12M	1.24M	2.56M	-4.35M	0.60M	-1.70M	0.71M	-1.90M	0.39M	0.92M	1.13M	-2.64M
Investing Activities
Capital Expenditures (Quarter)	1.50M	10.61M	-8.47M	5.28M	-2.22M	-2.80M	20.37M	0.63M	-0.58M	0.27M	-0.06M	0.01M	0.09M	0.72M	-0.46M	0.14M	-0.13M	0.54M	-0.49M	0.10M
Change in Acquisitions & Divestments (Quarter)				68.20M	59.35M	78.70M	38.50M	34.50M	40.48M	30.50M	1.14M	19.72M	32.49M	20.68M	8.32M	11.73M	-0.77M	34.78M
Cash from Investing Activities (Quarter)	-3.24M	-168.43M	-62.58M	16.43M	30.21M	31.03M	5.97M	8.06M	25.09M	30.49M	-14.92M	-4.49M	21.61M	-30.10M	14.10M	22.30M	24.99M	8.86M	-0.07M	-0.01M
Financing Activities
Other financing activities (Quarter)	1.37M	18.46M						0.50M	0.12M			3.24M	-3.24M		3.24M					0.41M
Change in Capital Stock
Shares Issued (Quarter)	0.03M	0.28M	188.20M	0.01M	0.26M	0.01M	77.11M		3.90M	3.90M		0.01M	0.57M	-0.58M		49.34M	-49.27M	0.29M	1.93M
Shares Repurchased (Quarter)		0.00M
Preferred Shares Issued (Quarter)	-0.01M
Misc.
Cash from Financing Activities (Quarter)	-1.30M	190.27M	-0.02M	0.01M	0.26M	0.01M	77.49M	-0.50M	4.18M		0.37M	46.77M	0.57M	0.03M	0.38M	50.26M	-0.48M	0.38M	58.24M	-0.41M
Change in Cash (Quarter)	-16.55M	5.19M	-78.95M	-12.31M	5.04M	3.48M	60.78M	-22.73M	3.04M	6.85M	-36.47M	13.62M	-1.43M	-49.90M	-3.91M	49.45M	8.90M	-6.36M	44.23M	-19.66M
Free Cash Flow (Quarter)	-13.52M	-27.27M	-7.88M	-34.04M	-23.21M	-24.76M	-43.05M	-30.92M	-25.64M	-23.90M	-21.86M	-28.67M	-23.71M	-20.56M	-17.93M	-23.25M	-15.48M	-16.14M	-13.45M	-19.33M
Net Cash Flow (Quarter)	-16.55M	5.19M	-78.95M	-12.31M	5.04M	3.48M	60.78M	-22.73M	3.04M	6.85M	-36.47M	13.62M	-1.43M	-49.90M	-3.91M	49.45M	8.90M	-6.36M	44.23M	-19.66M

Research Tools

Tenaya Therapeutics Cash Flow Statement (2020-2026) | TNYA

Create an account

Sign In

Reset Password